NCT06782282View on ClinicalTrials.gov

A Study to Learn About How Well the Prevnar 20 Vaccine Works for Pneumonia in People Who Are 65 Years and Older

Active, not recruitingOBSERVATIONAL
Enrollment

22,234,435

Participants

Timeline

Start Date

January 20, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Community-Acquired Pneumonia (CAP)
Trial Locations (1)

10017

Pfizer United States, New York

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT06782282 - A Study to Learn About How Well the Prevnar 20 Vaccine Works for Pneumonia in People Who Are 65 Years and Older | Biotech Hunter | Biotech Hunter